Dati del progetto

• IATI IDXM-DAC-6-4-012568-01-0
• Inizio previsto 16/12/2021
• Fine prevista 31/12/2022
• Inizio effettivo 21/01/2022
• Fine effettiva 13/02/2023
• Bi/Multilaterale Bilateral
• Stato Chiuso
• Tied status Slegato

Settori

• 12264 - COVID-19 control 100.0%

Policy marker

• Uguaglianza di Genere Non pertinente

Obiettivi

• 13.1 - Strengthen resilience and adaptive capacity to climate-related hazards and natural disasters in all countries
• 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
• 3.8 - Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
• 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
• 3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks